Helsmoortel-van der aa syndrome is a rare genetic condition that mainly affects brain development and learning. Many living with Helsmoortel-van der aa syndrome are recognized in infancy or childhood because of developmental delay, speech delay, low muscle tone, or features of autism, although early signs of Helsmoortel-van der aa syndrome can vary. Not everyone will have the same experience. Helsmoortel-van der aa syndrome is lifelong, and treatment focuses on support such as speech, physical, and occupational therapy, with other care based on a person’s needs. Life expectancy is not well defined and can vary, but many people with Helsmoortel-van der aa syndrome need ongoing developmental and medical follow-up rather than emergency treatment alone.
How many people live with Helsmoortel-van der aa syndrome?
There is no firm worldwide count for Helsmoortel-van der Aa syndrome, but more than 200 people have been identified globally so far (GeneReviews, 2024). A separate U.S. estimate is not consistently published, so there is no reliable national count to report.
Overview
Helsmoortel-van der aa syndromeSymptoms
Helsmoortel-van der Aa syndrome often affects development, learning, and behavior. Common features include delayed speech and motor skills, low muscle tone, autism-like traits, feeding problems, and sometimes seizures or distinctive facial features.
Outlook and prognosis
For people with Helsmoortel-van der Aa syndrome, outlook varies, but many continue to make progress in speech, learning, and daily skills with steady support. Long-term needs often include help with development, behavior, and sometimes seizures or autism-related challenges.
Causes and risk factors
Helsmoortel-van der Aa syndrome is caused by an ADNP gene change, usually new rather than inherited. No lifestyle or environmental causes are known. Family risk is low unless a parent carries the change.
Genetic influences
Genetics are central to Helsmoortel-van der Aa syndrome, because it is caused by a change in the ADNP gene. The exact genetic change can influence how Helsmoortel-van der Aa syndrome affects learning, behavior, speech, and overall development.
Diagnosis
Helsmoortel-van der Aa syndrome is usually suspected from clinical features and developmental history, then confirmed with genetic tests. The genetic diagnosis of Helsmoortel-van der Aa syndrome may also include imaging or other checks to look for related findings.
Treatment and drugs
Helsmoortel-van der Aa syndrome is treated with supportive, day-to-day care. Many benefit from speech, occupational, physical, and behavioral therapy, plus school support. Doctors also treat issues such as seizures, sleep problems, feeding difficulties, constipation, and vision or hearing concerns.
Symptoms
Helsmoortel-van der Aa syndrome can affect how a child communicates, learns, moves, and handles everyday routines from an early age. For many people with Helsmoortel-van der Aa syndrome, the earliest concerns are delayed milestones, limited speech, or differences in social interaction. The early features of Helsmoortel-van der Aa syndrome often become noticeable when a child is slower to sit, walk, talk, or manage feeding and sleep. Features vary from person to person, and some children have mild challenges while others need more day-to-day support.
Many children reach milestones such as sitting, walking, or self-feeding later than expected. In daily life, this can mean needing extra therapy, more practice, and more support with routines.
Speech and language are often markedly delayed, and some children use few words or remain nonverbal. Some may communicate better with gestures, pictures, tablets, or other supportive tools.
Many living with Helsmoortel-van der Aa syndrome show autistic features, such as reduced eye contact, repetitive behaviors, or strong preferences for sameness. This can make play, transitions, and busy social settings harder to manage.
Low muscle tone can make babies feel floppy and can affect posture, balance, and coordination later on. What once felt effortless for peers, like climbing stairs or sitting upright for long periods, may take more effort.
How people usually first notice Helsmoortel-van der aa syndrome?
How Helsmoortel-Van der Aa syndrome is first noticed often begins in infancy or early childhood, when families or doctors see developmental delay, especially delayed speech and language, low muscle tone that can make a baby seem unusually floppy, or feeding difficulties early on. As children grow, many living with Helsmoortel-Van der Aa syndrome are first recognized because of learning differences, autism-related traits or other behavior differences, and sometimes distinctive facial features that prompt a genetics evaluation. In some cases, the condition is suspected before birth because of prenatal testing, but more often the first signs of Helsmoortel-Van der Aa syndrome appear gradually during routine checkups as a child is not meeting expected developmental milestones.
Types of Helsmoortel-van der aa syndrome
No distinct types of Helsmoortel-van der Aa syndrome are widely recognized.
Can I slow down the onset of symptoms?
No. Helsmoortel-van der Aa syndrome is a genetic condition that is present from birth, and there is no good evidence that diet, exercise, supplements, or other lifestyle changes can meaningfully delay when symptoms begin; early speech, movement, daily-living, and behavior support may still help a child build skills and cope with challenges, but that is not the same as preventing the condition. There is also no proven medicine to stop it from starting, although regular early checkups for learning, behavior, sleep, feeding, vision, and other health needs are important, and research is still ongoing.
What genetics can tell you about symptoms
Genetics can explain part of why people with Helsmoortel-van der Aa syndrome can look different from one another, even though the condition is caused by changes in the same gene, called ADNP. Different genetic changes may be linked to differences in speech and learning problems, behavior, muscle tone, feeding issues, sleep, or when developmental delays first become clear, but doctors still cannot predict every symptom or its exact severity from the genetic result alone. In day-to-day life, this means genetic testing can help confirm the diagnosis and give some clues about what to watch for, but it usually cannot give a precise forecast for how symptoms will unfold in one child.
Causes and risk factors
A change in the ADNP gene causes Helsmoortel-van der Aa syndrome. Most often, this gene change is new in the child and was not inherited from either parent. Less often, it is passed down from a parent, so family history is the main known risk factor. Genetic testing can sometimes clarify your personal risk and confirm the genetic cause of Helsmoortel-van der Aa syndrome. Lifestyle and environmental factors are not known to cause Helsmoortel-van der Aa syndrome, but sleep, other health conditions, and early support can affect day-to-day challenges.
What are the most common causes or risk factors?
Helsmoortel-van der Aa syndrome is most often caused by a change in a gene called ADNP, and in many families this change happens for the first time by chance around conception, so it is not caused by anything a parent did or did not do. Less often, the gene change is passed down from a parent, so a family history of the condition or of the same gene change is the main known risk factor. There are no known lifestyle, diet, or environmental risk factors that have been shown to cause this syndrome.
Environmental and biological risk factors
For Helsmoortel-van der Aa syndrome, there are no well-proven environmental causes that parents can control. Awareness of both biological and environmental influences helps you feel prepared. Most cases seem to arise as a new, chance event very early in development, so known risk factors for Helsmoortel-van der Aa syndrome are limited and still being studied.
Helsmoortel-van der Aa syndrome usually happens as a new, unplanned change early in development. This means most families have no warning signs beforehand.
In some rare developmental conditions, older paternal age may slightly raise the chance of new changes arising in sperm. For Helsmoortel-van der Aa syndrome, this has not been confirmed as a clear risk factor.
Older maternal age is not known to be a major risk factor for Helsmoortel-van der Aa syndrome. This differs from some chromosome conditions where maternal age plays a clearer role.
No specific medicine, food, infection, or routine activity during pregnancy has been proven to cause Helsmoortel-van der Aa syndrome. Plenty of people with similar exposures live without developing the condition.
Genetic risk factors
When families look into the genetic causes of Helsmoortel-van der Aa syndrome, the answer is usually a harmful change in a gene called ADNP. Most cases happen for the first time in the child, so there may be no family history. Less often, the change is inherited in an autosomal dominant pattern, meaning one altered copy of the gene can cause the condition. In some cases, genetic testing can give a clearer picture of your personal risk.
ADNP gene: A harmful change in ADNP is the main genetic cause of Helsmoortel-van der Aa syndrome. This gene helps guide early brain and body development, so a change can affect many systems.
New change: Most children with Helsmoortel-van der Aa syndrome have a new ADNP change that happened for the first time around conception. In these families, the parents usually do not carry the change in their blood and did not do anything to cause it.
Inherited pattern: If a parent carries an ADNP change, it can be passed on in an autosomal dominant pattern. That means each pregnancy has a 1 in 2, or 50%, chance of inheriting the changed gene.
Parental mosaicism: Sometimes a parent has the ADNP change in only some of their cells, which is called mosaicism. Standard blood testing may miss this. Because of that, recurrence risk can be low but not zero even when neither parent is found to carry the change in blood.
ADNP deletion: Rarely, the cause is a missing piece of chromosome 20 that includes the ADNP gene rather than a smaller change within the gene itself. Losing the gene in this larger way can lead to the same syndrome.
Lifestyle risk factors
In Helsmoortel-van der Aa syndrome, lifestyle habits do not cause the condition, but they can meaningfully affect day-to-day function, comfort, and complications. Because this syndrome often involves developmental delay, autism-related traits, low muscle tone, sleep problems, feeding difficulties, and constipation, daily routines can either support or worsen symptoms. Families asking how lifestyle affects Helsmoortel-van der Aa syndrome should focus on habits that improve participation, safety, sleep, digestion, and regulation.
Irregular sleep schedules, late bedtimes, and overstimulating evenings can worsen sleep disruption, daytime irritability, and attention difficulties. A consistent bedtime routine, a calm sleep environment, and steady wake times may improve sleep quality and daytime regulation.
Too little movement can worsen low muscle tone, poor endurance, balance problems, and constipation in children with Helsmoortel-van der Aa syndrome. Regular, adapted physical activity and guided motor play may support strength, coordination, and daily function.
Limited food variety, rushed meals, or textures that are hard to manage can increase feeding stress and reduce nutritional intake. Structured mealtimes and individualized feeding strategies may help children who have oral-motor challenges, selective eating, or slow eating.
Low fiber intake and poor hydration can aggravate constipation, which is common in this condition and can worsen discomfort, sleep, and behavior. Adequate fluids and fiber, when tolerated, may support more regular bowel habits.
Risk prevention
Helsmoortel-van der Aa syndrome is a genetic condition, so there is no known way to prevent the syndrome itself from occurring. For many living with Helsmoortel-van der Aa syndrome, prevention focuses on lowering the risk of complications, supporting development, and catching problems early. Daily life may involve speech delays, learning needs, or behavior challenges, so early support can make a real difference at home, school, and in medical care. Prevention is flexible—it adapts to your life and health background.
Early speech, physical, occupational, and developmental therapy can help children with Helsmoortel-van der Aa syndrome build skills and avoid losing ground. Starting support early may reduce the day-to-day impact of movement, communication, and learning difficulties.
Ongoing follow-up with a pediatrician and the right specialists can help spot concerns before they become bigger problems. This is especially helpful in Helsmoortel-van der Aa syndrome, where needs can vary widely from one child to another.
Some people with Helsmoortel-van der Aa syndrome develop seizures, so quick evaluation of staring spells, unusual movements, or sudden confusion matters. Early treatment may help lower the risk of injury and other seizure-related complications.
Poor sleep can worsen behavior, attention, and learning, so healthy sleep routines are worth protecting. If snoring, frequent waking, or marked daytime tiredness show up, discussing these early symptoms of Helsmoortel-van der Aa syndrome with a doctor can help guide care.
Can you prevent Helsmoortel-van der aa syndrome?
No, Helsmoortel-van der Aa syndrome usually cannot be prevented because it is caused by a change in a gene, and this often happens by chance before birth. There is no known diet, medicine, or lifestyle change that has been shown to stop it from happening. If a family already has a child with this condition, or a parent is known to carry the gene change, a genetics expert can help explain the chance of it happening again and talk through testing options for a future pregnancy.
Transmission
Helsmoortel-van der Aa syndrome is not infectious, so it cannot spread from one person to another through touch, the air, blood, food, or sex. Instead, how Helsmoortel-van der Aa syndrome is inherited depends on a change in a gene that is usually new in the child and was not passed down from either parent. In a smaller number of families, a parent also carries the gene change and can pass it on, and then each pregnancy has a 1 in 2, or 50%, chance of the child inheriting it. A genetics specialist can explain the genetic transmission of Helsmoortel-van der Aa syndrome and whether testing may help clarify the chance for future children.
When to test your genes
Consider genetic testing when a child has unexplained developmental delay, limited or late speech, low muscle tone, autism features, or seizures, especially if several occur together. Testing can confirm Helsmoortel-van der Aa syndrome, guide developmental, neurologic, and behavioral care, and help clarify recurrence risk for the family.
Diagnosis
Helsmoortel-van der Aa syndrome is usually suspected when a child has a certain pattern of developmental and physical features, such as delays in speech or learning, low muscle tone, feeding difficulties, or traits linked with autism. Doctors usually begin by looking closely at growth, development, behavior, and any birth differences, then confirm the diagnosis with genetic testing. Getting a diagnosis is often a turning point toward answers and support.
The first clue is often a combination of developmental delay, speech delay, low muscle tone, feeding problems, or differences in behavior and social communication. No single sign proves Helsmoortel-van der Aa syndrome, but this pattern can make doctors strongly suspect it.
A detailed family and health history can help show when symptoms began and whether there were early feeding issues, seizures, or sleep problems. This also helps doctors see whether the findings fit the usual picture of Helsmoortel-van der Aa syndrome or suggest another condition.
Doctors check growth, muscle tone, movement, head size, and any subtle facial or body features that may go along with the condition. The exam also helps identify related concerns that may need care, such as constipation, coordination problems, or signs of developmental delay.
The diagnosis of Helsmoortel-van der Aa syndrome is confirmed by finding a disease-causing change in the ADNP gene. This is usually done with genetic tests such as a gene panel, exome sequencing, or another DNA-based test ordered by a specialist.
How is Helsmoortel-van der aa syndrome diagnosed?
Helsmoortel-van der Aa syndrome is usually diagnosed after doctors put together a child’s developmental history, behavior and learning profile, and physical exam, looking for patterns such as delayed speech, low muscle tone, autism traits, or other body findings that can occur with the condition. Because these signs can overlap with many other conditions, doctors often use a blood or saliva genetic test to look for a change in the ADNP gene, which can confirm the diagnosis. Other tests, such as hearing, vision, heart, or brain checks, may be done to understand a person’s needs, but they do not diagnose the syndrome on their own.
Stages of Helsmoortel-van der aa syndrome
Helsmoortel-van der aa syndrome does not have defined progression stages. This is because it is a genetic developmental condition that is usually present from early childhood, rather than an illness that moves through clear step-by-step phases over time. Often the process begins when you notice changes in daily life, such as delayed speech, learning differences, low muscle tone, or behaviors linked with autism, which can overlap with the early symptoms of Helsmoortel-van der aa syndrome. Doctors usually diagnose it by combining a medical history, developmental assessment, physical exam, and genetic testing, then monitor progress over time based on communication, learning, behavior, sleep, and other day-to-day needs.
Outlook and prognosis
Outlook in Helsmoortel-van der Aa syndrome is highly variable, but most affected people survive into childhood and adulthood, with prognosis shaped mainly by the severity of intellectual disability, autism features, speech impairment, seizures, and medical complications such as feeding problems. The condition is generally not considered a progressive neurodegenerative disorder, so many individuals have a stable course, although developmental delays and lifelong support needs are common. Some children make meaningful gains in communication, motor skills, and daily functioning with early therapies, special education, and treatment of associated problems. Seizures, sleep disturbance, behavioral challenges, and gastrointestinal or nutritional issues can affect quality of life and may require ongoing multidisciplinary care. Published data are still limited because the syndrome is rare, but early death does not appear to be a typical feature, and there is no clear evidence of markedly reduced life expectancy in most reported cases. Overall, long-term outcomes depend on each person’s symptom burden, response to supportive care, and presence of additional medical issues.
Long-term effects
For many living with Helsmoortel-van der Aa syndrome, long-term effects often center on development, learning, behavior, and day-to-day independence. The long-term picture is often quite variable, with some people needing lifelong support and others gaining skills steadily over time. In childhood, school years, and adulthood, the main challenges usually relate to communication, thinking skills, behavior, and associated medical issues rather than a steadily worsening course. It’s important to remember that long-term doesn’t always mean progressive, although needs can change with age.
Many people with Helsmoortel-van der Aa syndrome continue to have developmental delay and intellectual disability into adult life. This can affect school progress, problem-solving, money skills, and how much support is needed for daily tasks.
Speech delay often remains a long-term feature, and some people continue to use few words or rely on gestures, pictures, or devices to communicate. Early symptoms of Helsmoortel-van der Aa syndrome often include delayed language, and this can continue to shape learning and social life over time.
Autism traits, attention problems, anxiety, impulsivity, or repetitive behaviors may continue across many years. Some effects may be mild, while others can be more disruptive at home, in school, or later in work and relationships.
As people grow older, they may still need help with dressing, meals, travel, planning, or managing routines safely. The level of independence varies widely, and adulthood can look very different from one person to another.
How is it to live with Helsmoortel-van der aa syndrome?
Living with Helsmoortel-Van der Aa syndrome can affect many parts of daily life, often through developmental delay, speech and learning differences, low muscle tone, behavior differences such as autism traits or attention difficulties, and sometimes feeding, sleep, or seizure-related challenges. For many people with this condition, that can mean needing extra support with communication, school, routines, and everyday tasks, although day-to-day needs vary widely from one person to another. Life around the family is often shaped by appointments, therapies, advocacy, and careful planning, which can be demanding, but many families also build strong routines, celebrate steady progress, and find meaningful ways to support independence and connection.
Treatment and drugs
Helsmoortel-van der Aa syndrome does not have a cure yet, so treatment focuses on the specific challenges each person is dealing with, such as delays in speech and learning, behavior differences, sleep problems, feeding issues, constipation, or seizures. Many living with Helsmoortel-van der Aa syndrome benefit from early, steady support like physical, occupational, speech, and behavioral therapy, which can help with communication, movement, daily skills, and school participation. Doctors may also use medicines to treat symptoms when needed, for example to help control seizures, improve sleep, ease constipation or reflux, or support attention and behavior. Treatment often looks different for each person, and care is usually coordinated by a team that may include a pediatrician, neurologist, developmental specialist, therapists, and school supports. Because needs can change over time, regular follow-up helps families adjust the plan and spot the best options for day-to-day life.
Can you cure Helsmoortel-van der aa syndrome?
No, there is no cure for Helsmoortel-van der Aa syndrome right now. Because it is caused by a change in a gene, treatment does not remove the condition, but it can help with day-to-day challenges such as learning, speech, behavior, movement, sleep, or seizures. Many living with this syndrome benefit from early therapies, school support, and regular care from doctors who treat the symptoms that matter most to them.
Non-drug treatment
Daily life with Helsmoortel-van der Aa syndrome often centers on communication, learning, behavior, movement, and feeding, so non-drug care usually brings together several therapies rather than relying on one approach. Early support can make a real difference, especially when a child is having delays with speech, walking, or social interaction. Managing this condition often means building therapy into everyday routines at home, school, and clinic visits. Not every approach works the same way, so care is usually tailored to the person’s strengths, needs, and age.
Speech and language therapy can help with early communication skills, understanding words, and expressing needs. For children who speak very little, therapists may introduce picture systems or communication devices so daily tasks and social moments are less frustrating.
Occupational therapy supports everyday skills such as dressing, eating, writing, and playing. It can also help with sensory differences, so things like noisy classrooms, certain fabrics, or toothbrushing may feel more manageable.
Physical therapy can help with low muscle tone, balance, coordination, and delayed walking. For many, treatment begins not at the pharmacy, but with guided practice for climbing stairs, getting up from the floor, and moving more safely through the day.
Behavioral therapy can support attention, flexibility, emotional regulation, and social skills. This may be especially helpful when early symptoms of Helsmoortel-van der Aa syndrome include autism-related traits, frequent meltdowns, or trouble with changes in routine.
Your genes may have an impact on how drugs work for you
For people living with Helsmoortel-Van der Aa syndrome, medicines are often used to help with day-to-day issues such as seizures, sleep problems, attention, anxiety, or behavior, and the way these medicines work can vary a lot from one person to another. Part of that difference may come from a person’s genetic change, which can affect how the brain and body respond, so one child may improve on a usual dose while another may have more side effects or need a different plan. At this time, there is no well-established gene-based medication guide used routinely just for this syndrome, so treatment is usually adjusted carefully based on symptoms, benefits, and side effects over time.
Pharmacological treatments
Daily life with Helsmoortel-van der Aa syndrome often involves treating specific problems such as seizures, sleep trouble, attention difficulties, constipation, or reflux rather than using one medicine for the syndrome itself. There is currently no drug that corrects the underlying genetic change, so treatment for Helsmoortel-van der Aa syndrome is usually tailored to each person’s symptoms. Not everyone responds to the same medication in the same way. Doctors usually choose medicines based on the issues causing the most disruption at home, school, or during sleep.
If someone with Helsmoortel-van der Aa syndrome has epilepsy, doctors often use standard anti-seizure drugs such as levetiracetam, valproate, lamotrigine, or oxcarbazepine. The choice depends on seizure type, age, and side effects, and treatment is adjusted over time if seizures continue or the medicine causes problems.
Melatonin is commonly used when falling asleep is hard or sleep is broken through the night. Some children may also be prescribed clonidine or trazodone when sleep problems are severe, especially if poor sleep is affecting daytime behavior and learning.
Medicines used for attention-deficit/hyperactivity disorder, such as methylphenidate, amphetamine-based stimulants, guanfacine, clonidine, or atomoxetine, may help with focus, impulsivity, or high activity levels. Finding the right medication can be a process of trial, patience, and adjustment.
When irritability, aggression, severe anxiety, or repetitive behaviors are causing major distress, doctors may sometimes use medicines such as sertraline, fluoxetine, risperidone, or aripiprazole. These are usually considered only when behavioral supports alone are not enough, because side effects need close follow-up.
Genetic influences
For many living with Helsmoortel-van der Aa syndrome, the genetic cause is known: it is usually linked to a change in the ADNP gene, which is important for early brain development. Most of these gene changes happen for the first time in the child and are not inherited from either parent. It’s natural to ask whether family history plays a role. In some families, though, the condition can be passed on in an autosomal dominant pattern, which means a parent with the ADNP gene change has a 1 in 2, or 50%, chance of passing it to each child. This is why people often ask whether Helsmoortel-van der Aa syndrome is inherited, and the answer depends on whether the gene change started new in the child or was already present in a parent. Genetic testing can confirm the ADNP change and help families understand recurrence risk for future pregnancies.
Is Helsmoortel-van der aa syndrome genetic?
Genetics are central to Helsmoortel-van der Aa syndrome, because it is caused by a change in the ADNP gene. The exact genetic change can influence how Helsmoortel-van der Aa syndrome affects learning, behavior, speech, and overall development.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a common, normal part of human biology. Most do not have a direct impact on health and are simply part of natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many families, treatment is less about one single medicine and more about easing day-to-day problems such as seizures, sleep trouble, constipation, reflux, or attention and behavior challenges. In Helsmoortel-van der Aa syndrome, the underlying cause is usually a change in the ADNP gene, and that genetic result helps doctors confirm the diagnosis and decide which checks, therapies, and specialists may be most helpful. At the moment, there is no approved drug that corrects the gene change itself, so treatment for Helsmoortel-van der Aa syndrome is usually based on the symptoms each person has. Not every difference in response is genetic, but the genetic diagnosis can still guide care because people with Helsmoortel-van der Aa syndrome often have a particular mix of developmental, behavioral, and medical needs. For example, one child may need anti-seizure medicine, while another may benefit more from treatment for sleep, feeding, or bowel problems alongside speech, physical, and occupational therapy. If medicines cause side effects or do not seem to help, doctors usually adjust the plan step by step; routine pharmacogenetic testing is not currently a standard part of care for Helsmoortel-van der Aa syndrome itself.
Interactions with other conditions
Many living with Helsmoortel-van der aa syndrome have more than one health concern at the same time, so day-to-day life can involve more than developmental delay alone. Along with learning and behavior differences, some people with Helsmoortel-van der aa syndrome also have autism traits, attention difficulties, sleep problems, seizures, or low muscle tone, and these can affect each other. For example, poor sleep may make focus, irritability, or daytime behavior harder, while seizures or anti-seizure medicines can add to tiredness or learning challenges. Doctors call it a comorbidity when two conditions occur together. Some may also have feeding problems, constipation, or reflux, which can worsen sleep, comfort, and growth, especially in younger children. Because Helsmoortel-van der aa syndrome can look different from one person to another, regular follow-up helps make sure any linked conditions are recognized early and treated in a coordinated way.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Helsmoortel-van der aa syndrome?
Because Helsmoortel-van der Aa syndrome often causes delayed speech, learning difficulties, low muscle tone, and autism-like behavior, it can be mistaken for autism spectrum disorder or for a more general developmental delay. Doctors may also consider other genetic conditions that can look similar, especially fragile X syndrome and Rett syndrome, and sometimes cerebral palsy when movement and muscle-tone problems stand out early on. Genetic testing is often what helps tell these apart.
History
Parents and doctors often first notice that something is different when a child is slow to meet early milestones, has feeding or sleep difficulties, or seems to need more support with speech and learning than expected. For many families living with Helsmoortel-van der Aa syndrome, the history of the condition is quite recent, because it was only identified and described in the medical literature in the 2010s. Before that, many children were likely grouped under broader labels such as developmental delay, autism spectrum disorder, or intellectual disability without a more specific explanation.
As more children with a similar pattern of features were recognized, doctors began to see that this was a distinct syndrome rather than an unrelated mix of symptoms. In recent decades, awareness has grown, and that has made it easier for families to get a clearer diagnosis. This shift matters in everyday life: instead of years of scattered appointments with no unifying answer, many now reach a diagnosis sooner and can connect with specialists, therapists, and other families facing similar challenges.
Researchers later identified a genetic cause, which helped confirm that Helsmoortel-van der Aa syndrome was a real, recognizable condition. That said, the early symptoms of Helsmoortel-van der Aa syndrome can still vary a lot from one child to another. Some children mainly come to medical attention because of delays in speech and learning, while others are first assessed because of behavior differences, low muscle tone, feeding issues, or seizures.
The history of Helsmoortel-van der Aa syndrome is still being written. Because it is a newly recognized condition, much of what doctors know has come from combining careful family stories with newer genetic testing and long-term follow-up. That ongoing work is improving diagnosis, helping doctors understand the full range of features, and giving families more reliable information than was available even a few years ago.